VOR Earnings

Quarterly EPS
$-8.05
Q3 2024
$-4.55
Q4 2024
$-5.21
Q1 2025
$-251.24
Q2 2025
$-121.63
Q3 2025
$84.87
Q4 2025
$-5.11
Q1 2026
$-1.16
Q2 2026
Latest RevenueN/A
Latest Net Income-62810000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.160-62810000+99.5%
Q1 2026-$5.110-219585000+1.9%
Q4 2025$84.8701.7B+1,965.3%
Q3 2025-$121.630-812684000-1,410.9%
Q2 2025-$251.240-1573669000-2,963.9%
Q1 2025-$5.210-32486000+42.1%
Q4 2024-$4.550-30712000+41.2%
Q3 2024-$8.050-27559000+17.9%
Q2 2024-$8.200-27839000
Q1 2024-$9.000-30804000
Q4 2023-$7.740-26261000
Q3 2023-$9.800-33190000
Vor Biopharma (VOR) — Earnings